NCT05911269

Brief Summary

Demonstrate the feasibility of conducting an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in adolescent and young adult (AYA) cancer survivors with clinically-relevant anxiety.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
2mo left

Started Jan 2025

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Jan 2025Jul 2026

First Submitted

Initial submission to the registry

June 12, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 20, 2023

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 21, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

1.4 years

First QC Date

June 12, 2023

Last Update Submit

March 11, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Acceptability of TiMBRe

    mean scores for the Acceptability E-scale Items are ≥ 4/5

    up to 8 weeks post start of intervention

  • Demand of TiMBRe

    percent of patients recruited over three years

    up to 3 years from start of study

  • Adherence to TiMBRe

    percent of TiMBRe participants to complete the baseline and 8 weeks patient report measures

    From enrollment to end of treatment at 8 weeks

  • Practicality of TiMBRe

    percent of TiMBRe group participants self-report practicing music-based relaxation skills for at least 10 minutes on at least three days per week

    From enrollment to end of treatment at 8 weeks

Secondary Outcomes (2)

  • Identification of facilitators and barriers to virtual TiMBRe participation

    up to 8 weeks post start of intervention

  • Change in Anxiety management

    at baseline and eight weeks post initiation of treatment

Study Arms (2)

TiMBRe

EXPERIMENTAL

an eight-week, (45 min/week), theory driven, virtually-delivered, tailored music-based relaxation (TiMBRe) intervention to decrease anxiety in AYA cancer survivors with clinically-relevant anxiety.

Other: TiMBRe

Attention-Control

ACTIVE COMPARATOR

Standard of care study staff calls and cancer survivorship resources

Other: Control

Interventions

TiMBReOTHER

1 \& 2 Music Listening * Live music played by the music therapist (e.g., guitar, voice) and AYA selected music will be used to facilitate attention to the present moment and provide cues for breathing/relaxation. 3 \& 4 Music Facilitated Breathing * The therapist will lead participants in music facilitated breathing exercises using rhythmic features of the music to cue structured breathing for relaxation and self-awareness 5 \& 6 Music Facilitated Progressive Muscle Relaxation for Stress Reduction * Using music as a structured auditory cue for tensing and releasing of muscles. 7 Body Percussion * The therapist will lead participants in a hands-on body percussion activity to bring attention to the sound of rhythm, sensation in their hands and body. 8 Participants Choice * will be selected by the participant.

TiMBRe
ControlOTHER

Standard of care study staff calls and cancer survivorship resources

Attention-Control

Eligibility Criteria

Age15 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years old
  • at least one month post cancer treatment
  • report clinically relevant anxiety in the past seven days (PROMIS Anxiety 4a scores ≥ 55)35
  • speak/read English.

You may not qualify if:

  • prognosis less than 3 months
  • documentation of significant hearing impairment
  • plan to receive surgery, radiation, or chemotherapy for cancer treatment during the study period
  • plans in place to begin new psychosocial (i.e., cognitive behavioral therapy14 or mindfulness-based stress reduction15) or pharmacological treatments for anxiety during the study. Although, participants may continue psychosocial or pharmacological treatments for anxiety if the treatments were initiated at least eight weeks prior to study enrollment, the dose has not changed, and they report clinically relevant anxiety in the last week.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48118, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Timbre Perception

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Auditory PerceptionVestibulocochlear Physiological PhenomenaPhysiological Phenomena

Study Officials

  • Robert Knoerl

    University of Michigan Rogel Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Model Details: Explanatory-Sequential Mixed Methods Study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2023

First Posted

June 20, 2023

Study Start

January 21, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations